Submitted by Anonymous (not verified) on 14 November 2025 - 10:30
Human medicines European public assessment report (EPAR): Dovato, dolutegravir,lamivudine, Date of authorisation: 01/07/2019, Revision: 19, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Dovato, dolutegravir,lamivudine, Date of authorisation: 01/07/2019, Revision: 19, Status: Authorised